5705-0504 Screening compound: N-[(1E)-1-[3-(benzenesulfonyl)-2-(4-methoxyphenyl)imidazolidin-1-yl]-2-(morpholin-4-yl)ethylidene]-4-methylbenzene-1-sulfonamide

5705-0504 Screening compound: N-[(1E)-1-[3-(benzenesulfonyl)-2-(4-methoxyphenyl)imidazolidin-1-yl]-2-(morpholin-4-yl)ethylidene]-4-methylbenzene-1-sulfonamide
5705-0504 Screening compound: N-[(1E)-1-[3-(benzenesulfonyl)-2-(4-methoxyphenyl)imidazolidin-1-yl]-2-(morpholin-4-yl)ethylidene]-4-methylbenzene-1-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound 5705-0504
N-[(1E)-1-[3-(benzenesulfonyl)-2-(4-methoxyphenyl)imidazolidin-1-yl]-2-(morpholin-4-yl)ethylidene]-4-methylbenzene-1-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

5705-0504

Molecular Formula

C29H34N4O6S2 (C29 H34 N4 O6 S2)

Compound Name

N-[(1E)-1-[3-(benzenesulfonyl)-2-(4-methoxyphenyl)imidazolidin-1-yl]-2-(morpholin-4-yl)ethylidene]-4-methylbenzene-1-sulfonamide

IUPAC name

N-[(1E)-1-[3-(benzenesulfonyl)-2-(4-methoxyphenyl)imidazolidin-1-yl]-2-(morpholin-4-yl)ethylidene]-4-methylbenzene-1-sulfonamide

SMILES

Cc(cc1)ccc1S(/N=C(\CN1CCOCC1)/N(CC1)C(c(cc2)ccc2OC)N1S(c1ccccc1)(=O)=O)(=O)=O

InChI

InChI=1S/C29H34N4O6S2/c1-23-8-14-26(15-9-23)40(34,35)30-28(22-31-18-20-39-21-19-31)32-16-17-33(41(36,37)27-6-4-3-5-7-27)29(32)24-10-12-25(38-2)13-11-24/h3-15,29H,16-22H2,1-2H3/t29-/m0/s1

InChI Key

HGBGWPBQUJCXPD-LJAQVGFWSA-N

MDL Number (MFCD)

MFCD03828048

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

598.74

Hydrogen Bond Acceptors Count

13.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

3.624

Distribution Coefficient, logD

3.624

Water Solubility, LogSw

-3.62

Polar Surface Area

93.727

Acid Dissociation Constant (pKa)

23.43

Base Dissociation Constant (pKb)

4.42

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

34.50

5705-0504 in Drug Discovery

Included in Screening Libraries

PI3K-Targeted Library (17255 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with 5705-0504 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 5705-0504?
Check Price and Availability of 5705-0504, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 5705-0504 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 5705-0504
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 5705-0504
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 5705-0504 available by request